Importantly, we documented that combination of intratumoral IL-17 and IL-17RE densities were associated with HCC recurrences which can be divided into early recurrence (≤24 months), a true metastasis caused by dissemination of cancer cells, and late recurrence (>24 months) originating from de novo hepatocarcinogenesis [4]. The gene discussed is IL17A; the disease is cancer.